(FM) Inmunología
Departamento académico
Juan José
Lasarte Sagastibelza
Catedrático de Universidad
Publicaciones en las que colabora con Juan José Lasarte Sagastibelza (27)
2023
2022
-
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Science Advances, Vol. 8, Núm. 39
2021
-
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
-
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946
2019
-
Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses
Molecular Therapy, Vol. 27, Núm. 11, pp. 1892-1905
2017
-
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
PLoS ONE, Vol. 12, Núm. 9
2016
-
Immunostimulatory monoclonal antibodies and immunomodulation: Harvesting the crop
Cancer Research, Vol. 76, Núm. 10, pp. 2863-2867
-
MRP1-CD28 bi-specific oligonucleotide aptamers: Target costimulation to drug-resistant melanoma cancer stem cells
Oncotarget, Vol. 7, Núm. 17, pp. 23182-23196
2015
-
Genetic basis for clinical response to CTLA-4 blockade
New England Journal of Medicine
-
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116
2013
-
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88
-
Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance
Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944
2009
-
Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes
Scandinavian Journal of Immunology, Vol. 69, Núm. 2, pp. 80-89
2007
-
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ
International Journal of Cancer, Vol. 121, Núm. 6, pp. 1282-1295
-
The many faces of regulatory T cells
Inmunologia, Vol. 26, Núm. 1, pp. 29-41
2006
-
El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones viráles crónicas
Anales del sistema sanitario de Navarra, Vol. 29, Núm. 1, pp. 77-96
2005
-
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus
Vaccine, Vol. 23, Núm. 27, pp. 3493-3499
2003
-
A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage
Hepatology, Vol. 37, Núm. 2, pp. 461-470
-
CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination
Journal of Immunology, Vol. 171, Núm. 11, pp. 5931-5939
-
Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses
International Immunology, Vol. 15, Núm. 6, pp. 691-699